luni, 26 iunie 2017

Decizie importanta a judecatorilor europeni privind vaccinurile

Un francez a fost vaccinat, în 1999, împotriva hepatitei B. 

Un an mai târziu a făcut scleroză în plăci şi a murit în 2011. Înainte de imunizare, bărbatul avea o stare de sănătate excelentă şi nu existau antecendente ale acestei boli în familia sa [!!!!!!].


În urmă cu 11 ani, familia bărbatului a dat în judecată firma care a produs vaccinul şi a cerut despăgubiri. Dar justiţia franceză a dat dreptate companiei, deoarece nu se poate proba ştiinţific, fără nicio îndoială, că există o legătură între acel ser şi scleroza în plăci [seriooos? - dar EI au probat vreodata stiintific ca NU exista o legatura? - n.m.].

Cazul a ajuns în Luxemburg, la Curtea de Justiţie a Uniunii Europene. Judecătorii de acolo au decis că sunt suficiente indicii grave, precise și concordante, care să arate că vaccinul este cauza cea mai plauzibilă pentru apariţia bolii

Şi asta deoarece nu se poate demonstra ştiinţific faptul că scleroza în plăci a fost provocată de orice altceva. [INDICII GRAVE, PRECISE SI CONCORDANTE - in justitie nu se mai poate jongla ca in medicina, mai ales cand "medicina" colcaie de conflicte de interes si nu ar admite ca vaccinul cauzeaza ceva nici cand omul ar muri cu seringa infipta in brat!!]

Familia bărbatului poate invoca această decizie pentru a deschide un nou proces în Franţa.

BRAVO!!!!!



Avocatul Gheorghe Piperea a postat pe profilul sau de Facebook urmatorul mesaj:


Ieri, 21 iunie 2017, CJUE s-a pronuntat intr-un caz contra producatorului de vaccinuri Sanofi Pasteur, in care a retinut ca producatorul raspunde de daunele provocate de vaccin* chiar daca "cercetarea medicala nu stabileste si nici nu infirma existenta unei legaturi intre administrarea vaccinului si aparitia bolii de care este afectata persoana prejudiciata", cu conditia ca "anumite elemente de fapt invocate de reclamant [sa] constituie indicii grave, precise si concordante care permit sa se concluzioneze ca exista un defect al vaccinului si o legatura de cauzalitate intre acest defect si boala respectiva".

Reclamantul fusese obligat sa isi faca un vaccin contra hepatitei B. A facut vaccinul, dar a facut si scleroza in placi si, la 13 ani distanta, a decedat. Producatorul de vaccinuri a convins instanta de apel din Franta ca nu se poate stabili cu precizie stiintifica legatura de cauzalitate dintre vaccin si boala, asa ca prezumtiile stabilite in favoarea consumatorului de legislatia care sanctioneaza fabricarea si comercializarea de produse cu defecte nu mai joaca.

[Nota : cine se aseamana, se aduna, caci exact acesta este si "argumentul" banksterilor in cazul creditelor in monede toxice - ca nu se poate stabili cu precizie aritmetica evolutia defavorabila debitorului a cursului acelei monede** si, deci, nu se poate stabili vina lor in lantul cauzalitatii ruinei debitorilor lor].

In speta citata mai, jos, familia celui decedat a sesizat CJUE, care a stabilit ieri, 21 iunie 2017, ca indiciile grave, precise si concordante din care rezulta ca exista probabilitatea unor defecte ale vaccinului si a unei legaturi de cauzalitate intre aceste defecte si boala sau decesul consumatorului, pot fundamenta raspunderea pentru daune a producatorului.

Speta este de o importanta covarsitoare in domeniul medical, in general, dar mai ales in domeniul vaccinurilor, produse pentru care demisul guvern Grindeanu intentiona sa introduca obligativitatea, inclusiv pentru adulti, fara o verificare a traseului vaccinului de la producator la medicul care il administreaza, fara o verificare a certitudinii beneficiilor medicale si fara o verificare individualizata pe fiecare pacient a compatibilitatii si riscurilor concrete ale vaccinului.

Atat de importanta este decizia, incat presa noastra a tacut destul de consistent, iar cele doua-trei publicatii care au catadicsit, totusi, sa anunte aceasta speta, au facut-o cu grija mare, fara indicarea spetei si fara prea multe comentarii, in speranta ca lumea nu va sesiza stirea, in noianul vestilor despre motiunea de cenzura contra guvernului Grindeanu.

*Da, vaccinul poate afecta sanatatea si chiar viata unui om, desi lumea este convinsa doar de beneficiile (indiscutabile) ale vaccinului. [...]
**Francul elvetian era prezentat celor care se imprumutau in aceasta moneda exotica drept un vaccin, o imunizare la fluctuatiile impredictibile ale leului. Era moneda stabila prin excelenta. Ca si vaccinul, care prezinta ca singura certitudine stabilitatea vanzarilor si volumul ridicat al profitului producatorului, si CHF era o certitudine pentru creditori. Era, intr-adevar, stabil, dar nu pentru debitori, "pacientii" care, cica, se vaccinau pentru a preveni hemoragia de lei platibili in caz de inflatie.

http://curia.europa.eu/juris/document/document.jsf?text=&docid=192054&pageIndex=0&doclang=ro&mode=req&dir=&occ=first&part=1&cid=175296

Cu ajutorul lui Bogdan Popa (mii de multumiri!), stim ca scleroza multipla este un efect advers posibil al vaccinurilor, exista studii care confirma acest lucru:


Multiple sclerosis

Neurological manifestations are common following vaccinations (Huynh et al., 2008). In a case-control epidemiological study for serious adverse events reported in the hepatitis B vaccination exposed group compared to those that received tetanus vaccine, MS was prominent with an odds ratio of 5.2 (P<0.0003). Optic neuritis was also very commonly encountered (OR-14, p<0.0002) (Geier et al., 2005).

http://www.discoverymedicine.com/Hedi-Orbach/2010/02/04/vaccines-and-autoimmune-diseases-of-the-adult/

A case-control study of serious autoimmune adverse events following hepatitis B immunization.
https://www.ncbi.nlm.nih.gov/pubmed/16206512

Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study.

CONCLUSIONS: These findings are consistent with the hypothesis that immunization with the recombinant hepatitis B vaccine is associated with an increased risk of MS, and challenge the idea that the relation between hepatitis B vaccination and risk of MS is well understood.

https://www.ncbi.nlm.nih.gov/m/pubmed/15365133/


Encephalitis after hepatitis B vaccination: recurrent disseminated encephalitis or MS?

The persistent inflammatory activity observed clinically and on MRI in these patients is comparable with that usually observed in MS. Epidemiologic studies are currently testing the hypothesis of a triggering role of hepatitis B vaccination in CNS demyelination.

https://www.ncbi.nlm.nih.gov/pubmed/10430433

The data clearly show that up to 1993, the number of new cases of MS in France remained quite stable at 2,500 new cases a year. The following years, but especially from 1996, the number increased dramatically to 4,500 a year, and has stayed stable at this level since. The explanation is not entirely clear, but it could be that one of the proteins in the vaccine was very similar to a protein in myelin. Whatever the mechanism, because of this unique event in vaccination history, of such a large number of people getting vaccinated against hepatitis B in such a short time, and the resultant dramatic wave of new cases, it appears highly likely that hepatitis B vaccination can trigger MS.

https://overcomingms.org/new-study-strongly-suggests-hepatitis-b-vaccination-france-sparked-wave-new-cases-ms/

"In it, the Court ruled that the victim, an adult female, had contracted a form of demyelinating disease and MS, and eventually died, after receiving the Hepatitis B vaccine series. It was just the most recent case in a rash of rulings in the omnibus proceeding dealing with hepatitis B vaccine and “demyelinating diseases such as transverse myelitis (TM), Guillain-Barré syndrome (GBS), chronic inflammatory demyelinating disease (CIDP), and multiple sclerosis (MS),” according to court papers."

http://www.maxresistance.com/vaccines-causing-multiple-sclerosis-nurse-sues-over-h1n1-shot/

CNS demyelination and quadrivalent HPV vaccination.

“Vaccination is generally considered safe in patients with multiple sclerosis (MS). We report five patients who presented with multifocal or atypical demyelinating syndromes within 21 days of immunization with the quadrivalent human papilloma virus (HPV) vaccine, Gardasil. Although the target population for vaccination, young females, has an inherently high risk for MS, the temporal association with demyelinating events in these cases may be explained by the potent immuno-stimulatory properties of HPV virus-like particles which comprise the vaccine. A prospective case-control study of patients with MS or clinically isolated demyelinating syndromes receiving the Gardasil vaccine may provide relevant safety data in this population.”

https://www.ncbi.nlm.nih.gov/m/pubmed/18805844/

Demyelinating disease and polyvalent human papilloma virus vaccination

“Since its inception, the polyvalent vaccine against the human papilloma virus (HPV), Gardasil, has generated some controversies as a temporal relationship between the administrations of the vaccine and the development of a few autoimmune diseases, such as acute disseminated encephalomyelitis (ADEM), multiple sclerosis (MS) and Guillain–Barre syndrome have been reported.1–3 We encountered two cases whose initial presentation of CNS demyelination followed in close time relationship the administration of Gardasil vaccine and we discuss their possible association.

Case No 1
A 19-year-old woman received two doses of Gardasil, 3 months apart, and approximately 1 month after the second dose, she developed numbness to the right foot that within 1 day extended to the contralateral foot and was associated with mid-thoracic back pain. Her neurological examination was only significant for the altered perception to touch to the feet. Deep tendon reflexes were normal and plantar reflexes in flexion. MRI of cervical and thoracic spine revealed a total of three lesions with characteristic demyelinating appearance, one of those in the thoracic spine was contrast-enhancing (figure 1A–C). MRI brain demonstrated one additional white matter lesion also consistent with a demyelinating process.”

http://jnnp.bmj.com/content/82/11/1296.long
 
Revin cu textele traduse si in lb. romana!

Niciun comentariu:

Trimiteți un comentariu